Yulin Liao Selected Research

Ischemia

10/2016	FGF23 promotes myocardial fibrosis in mice through activation of β-catenin.
8/2015	Ablation of C/EBP homologous protein increases the acute phase mortality and doesn't attenuate cardiac remodeling in mice with myocardial infarction.
8/2015	Inhibition of microRNA-497 ameliorates anoxia/reoxygenation injury in cardiomyocytes by suppressing cell apoptosis and enhancing autophagy.
5/2013	Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function.
11/2012	Resveratrol improves myocardial ischemia and ischemic heart failure in mice by antagonizing the detrimental effects of fractalkine*.
6/2004	Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
9/2002	Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart.
1/2002	Adenosine-induced cardiac gene expression of ischemic murine hearts revealed by cDNA array hybridization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yulin Liao Research Topics

Disease

40	Neoplasms (Cancer) 04/2024 - 01/2008
27	Heart Failure 06/2023 - 10/2003
25	Myocardial Infarction 12/2023 - 02/2011
21	Hypertrophy 08/2023 - 09/2002
19	Cardiomegaly (Heart Hypertrophy) 12/2022 - 01/2002
17	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2012
16	Fibrosis (Cirrhosis) 06/2023 - 05/2013
15	Body Weight (Weight, Body) 01/2020 - 09/2002
11	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2014
10	Hypoxia (Hypoxemia) 01/2021 - 11/2011
10	Infarction (Infarctions) 05/2018 - 09/2002
9	Inflammation (Inflammations) 01/2022 - 01/2011
8	Reperfusion Injury 01/2021 - 09/2002
8	Ischemia 10/2016 - 01/2002
7	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 04/2006
7	Abdominal Aortic Aneurysm 01/2023 - 01/2019
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 09/2002
5	Atherosclerosis 02/2024 - 08/2011
5	Colonic Neoplasms (Colon Cancer) 11/2023 - 03/2019
5	Aneurysm (Aneurysms) 12/2022 - 01/2019
4	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 09/2010
4	Atherosclerotic Plaque (Atheroma) 01/2023 - 11/2013
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 05/2013
4	Cardio-Renal Syndrome 01/2022 - 01/2019
3	Aortic Aneurysm (Aneurysm, Aortic) 02/2024 - 01/2019
3	Infections 01/2022 - 01/2014
3	Hyperglycemia 01/2022 - 04/2006
3	Thrombosis (Thrombus) 11/2019 - 01/2012
3	Glucose Intolerance 05/2013 - 04/2006
3	Coronary Occlusion 12/2004 - 09/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2021
2	Stroke (Strokes) 11/2023 - 01/2019
2	ST Elevation Myocardial Infarction 01/2023 - 01/2018
2	Diabetes Mellitus 01/2022 - 05/2013
2	Ventilator-Associated Pneumonia 01/2022 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2021 - 04/2019
2	Emergence Delirium 08/2020 - 01/2020
2	Hemorrhage 01/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 11/2023 - 09/2002
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
11	Long Noncoding RNAIBA 12/2021 - 01/2017
9	Angiotensin IIIBA 08/2023 - 10/2003
8	CateninsIBA 08/2023 - 10/2016
8	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2018
7	Circular RNAIBA 11/2022 - 10/2017
5	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2021
5	LipidsIBA 02/2024 - 01/2015
5	salicylhydroxamic acid (SHAM)IBA 12/2023 - 10/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 07/2006
5	Messenger RNA (mRNA)IBA 01/2022 - 03/2010
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2002
5	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 01/2015
5	Adenosine (Adenocard)FDA LinkGeneric 10/2011 - 01/2002
4	Interleukin-6 (Interleukin 6)IBA 05/2023 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 03/2016 - 09/2005
4	Purinergic P1 Receptors (Adenosine Receptor)IBA 10/2011 - 01/2002
3	Cyclin D1IBA 08/2023 - 05/2017
3	EnzymesIBA 01/2023 - 02/2010
3	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2015
3	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2019 - 04/2015
3	UbiquitinIBA 01/2019 - 02/2006
3	Chemokine CX3CL1IBA 10/2016 - 12/2011
3	Small Interfering RNA (siRNA)IBA 01/2016 - 01/2014
3	CalcineurinIBA 04/2015 - 01/2014
3	Phosphotransferases (Kinase)IBA 10/2013 - 09/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2004 - 09/2002
2	Monoclonal AntibodiesIBA 11/2023 - 09/2010
2	Glycogen Synthase (Synthase I)IBA 08/2023 - 06/2023
2	CytokinesIBA 01/2023 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2019
2	Cysteine (L-Cysteine)FDA Link 03/2022 - 01/2021
2	VimentinIBA 03/2022 - 01/2021
2	Streptozocin (Streptozotocin)FDA Link 01/2022 - 09/2016
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 01/2022
2	Epinephrine (Adrenaline)FDA LinkGeneric 10/2021 - 12/2012
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2021 - 04/2015
2	CollagenIBA 01/2021 - 12/2018
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2021 - 01/2016
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 09/2002
2	Fibroblast Growth Factor-23IBA 01/2021 - 10/2016
2	Apolipoproteins E (ApoE)IBA 01/2020 - 01/2015
2	ApolipoproteinsIBA 01/2020 - 01/2015
2	Sirtuin 1IBA 12/2019 - 11/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 05/2017
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 01/2002
2	Atrial Natriuretic Factor (ANF)IBA 12/2018 - 01/2014
2	Folic Acid (Vitamin M)FDA LinkGeneric 10/2018 - 01/2015
2	olmesartanIBA 05/2018 - 08/2014
2	Glycogen Synthase KinasesIBA 05/2018 - 05/2017

Therapy/Procedure

21	Therapeutics 11/2023 - 01/2002
12	Microbubbles 01/2023 - 08/2011
7	Immunotherapy 01/2023 - 01/2019
6	Drug Therapy (Chemotherapy) 02/2024 - 01/2012
4	Aftercare (After-Treatment) 04/2024 - 11/2015
3	Ultrasonic Therapy 01/2023 - 10/2018
2	Transplantation 02/2024 - 12/2016
2	Percutaneous Coronary Intervention 01/2023 - 01/2020
2	Adjuvant Chemotherapy 01/2022 - 01/2020
2	Sutures (Suture) 01/2021 - 01/2020
2	Length of Stay 08/2020 - 01/2020